Skip to main content

Table 2 Results for of the pediatric AML analysis

From: Gene-set distance analysis (GSDA): a powerful tool for gene-set association analysis

Method

Chloroma

logWBC

EFS

GSDA (t-test)

0.020

\(< 10^{-29}\)

0.060

GSDA (perm)

0.029

\(<10^{-6}\)

0.051

GSEA

0.030

0.008

0.572

GSA

0.512

0.688

0.114

SAFE

0.561

0.014

0.336

GT

0.014

\(< 10^{-5}\)

0.250

TOTS

0.960

\(< 0.001\)

0.217

POST

0.027

\(< 10^{-5}\)

0.130

PIANO (Wilcoxon)*

0.804

0.004

0.209

PIANO (Fisher)*

0.0004

\(< 10^{-37}\)

0.092

PIANO (Stouffer)*

0.004

\(< 10^{-27}\)

0.164

PIANO (Reporter)*

0.742

0.004

0.288

PIANO (Tail Strength)*

0.744

0.016

0.239

PIANO (Mean)*

0.836

0.030

0.217

PIANO (Median)*

0.834

0.001

0.316

PIANO (Sum)*

0.858

0.042

0.221

PIANO (MaxMean)*

0.116

0.011

1.000

PIANO (GSEA)*

0.039

0.028

1.000

PIANO (FGSEA)*

0.014

0.029

1.000

PIANO (PAGE)*

0.044

0.096

0.112

  1. The table shows the p values for each method for the association the expression of the KEGG AML pathway with clinical characteristics and survival in pediatric AML
  2. *PIANO was performed with only the gene-level statistics with signifMethod=’nullDist’ for Wilcoxon, Fisher, Stouffer, and Reporter methods and signifMethod = ‘geneSampling’ and 999 permutations for the other methods